about
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug...
Read More
0.39
-0.02
(-4.88%)
142.9K
XNAS Volume
XNAS 29 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Athira Pharma Inc is on 01 Aug 2025 for the purpose of Athira Pharma Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Athira Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..